SELLING VYTORIN THROUGH $60 M OF CME

Arteries Clogged by Moolah


Cardiobrief, via Dow Jones newswire, reports on the extraordinary sums MSP provided to CME related to Vytorin. One single grant amount to $6 M.

See: http://cardiobrief.org/2009/09/16/senate-investigation-uncovers-huge-expenditures-for-vytorin-cme/

The information emerged through a Senate investigation.

I'm glad that pharma is supporting health-care reform.